What's wrong with epigenetics in Huntington's disease?

Neuropharmacology

Volumn 80, Issue , 2014, Pages 103-114

  Valor, Luis M ^a   Guiretti, Deisy ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Amelioration; DNA methylation; HDAC; Histone; KAT; Polyglutamine; Post translational modification

Indexed keywords

HISTONE; NERVE PROTEIN; NOOTROPIC AGENT;

AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BRAIN; DNA METHYLATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; HUNTINGTON DISEASE; METABOLISM; NERVE CELL; PROTEIN PROCESSING;

ANIMALS; BRAIN; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HUMANS; HUNTINGTON DISEASE; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURONS; NOOTROPIC AGENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84898894222     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.10.025     Document Type: Review

References (131)

1. K. Anamika, A.R. Krebs, J. Thompson, O. Poch, D. Devys, and L. Tora Lessons from genome-wide studies: an integrated definition of the coactivator function of histone acetyl transferases Epigenetics Chromatin 3 2010 18
2. O.A. Andreassen, A. Dedeoglu, V. Stanojevic, D.B. Hughes, S.E. Browne, C.A. Leech, R.J. Ferrante, J.F. Habener, M.F. Beal, and M.K. Thomas Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression Neurobiol. Dis. 11 2002 410 424 (Pubitemid 36269126)
3. F.H. Bardai, P. Verma, C. Smith, V. Rawat, L. Wang, and S.R. D'Mello Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity J. Neurosci. 33 2013 11833 11838
4. G. Bates, P. Harper, and L. Jones Huntington's Disease 2004 Oxford University Press
5. E.A. Bates, M. Victor, A.K. Jones, Y. Shi, and A.C. Hart Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity J. Neurosci. 26 2006 2830 2838 (Pubitemid 43357867)
6. D.C. Bedford, and P.K. Brindle Is histone acetylation the most important physiological function for CBP and p300? Aging (Albany NY) 4 2012 247 255
7. C.L. Benn, T. Sun, G. Sadri-Vakili, K.N. McFarland, D.P. DiRocco, G.J. Yohrling, T.W. Clark, B. Bouzou, and J.H. Cha Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner J. Neurosci. 28 2008 10720 10733
8. C.L. Benn, R. Butler, L. Mariner, J. Nixon, H. Moffitt, M. Mielcarek, B. Woodman, and G.P. Bates Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's disease PLoS One 4 2009 e5747
9. J.S. Bett, C.L. Benn, K.Y. Ryu, R.R. Kopito, and G.P. Bates The polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease J. Cell. Mol. Med. 13 2009 2645 2657
10. A. Bobrowska, P. Paganetti, P. Matthias, and G.P. Bates Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington's disease PLoS One 6 2011 e20696
11. A. Bobrowska, G. Donmez, A. Weiss, L. Guarente, and G. Bates SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo PLoS One 7 2012 e34805
12. L. Bodai, J. Pallos, L.M. Thompson, and J.L. Marsh Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's disease Neurodegener Dis. 9 2012 104 106
13. C. Bonisch, and S.B. Hake Histone H2A variants in nucleosomes and chromatin: more or less stable? Nucleic Acids Res. 40 2012 10719 10741
14. J.M. Boutell, P. Thomas, J.W. Neal, V.J. Weston, J. Duce, P.S. Harper, and A.L. Jones Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin Hum. Mol. Genet. 8 1999 1647 1655 (Pubitemid 29423873)
15. S. Braun, and H.D. Madhani Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin EMBO Rep. 13 2012 619 630
16. J. Cao, and Q. Yan Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer Front. Oncol. 2 2012 26
17. E. Cattaneo, C. Zuccato, and M. Tartari Normal huntingtin function: an alternative approach to Huntington's disease Nat. Rev. Neurosci. 6 2005 919 930 (Pubitemid 41753086)
18. S.Y. Cong, B.A. Pepers, B.O. Evert, D.C. Rubinsztein, R.A. Roos, G.J. van Ommen, and J.C. Dorsman Mutant huntingtin represses CBP, but not p300, by binding and protein degradation Mol. Cell. Neurosci. 30 2005 560 571
19. C. Crosio, E. Heitz, C.D. Allis, E. Borrelli, and P. Sassone-Corsi Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons J. Cell Sci. 116 2003 4905 4914 (Pubitemid 38016697)
20. J.H. Cha Transcriptional signatures in Huntington's disease Prog. Neurobiol. 83 2007 228 248
21. A.S. Chen-Plotkin, G. Sadri-Vakili, G.J. Yohrling, M.W. Braveman, C.L. Benn, K.E. Glajch, D.P. DiRocco, L.A. Farrell, D. Krainc, S. Gines, M.E. MacDonald, and J.H. Cha Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease Neurobiol. Dis. 22 2006 233 241
22. G. Chen, X. Zou, H. Watanabe, J.M. van Deursen, and J. Shen CREB binding protein is required for both short-term and long-term memory formation J. Neurosci. 30 2010 13066 13077
23. J.Y. Chen, E. Wang, L. Galvan, M. Huynh, P. Joshi, C. Cepeda, and M.S. Levine Effects of the pimelic diphenylamide histone deacetylase inhibitor HDACi 4b on the R6/2 and N171-82Q mouse models of Huntington's disease PLoS Curr. 5 2013
24. C.T. Chiu, G. Liu, P. Leeds, and D.M. Chuang Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease Neuropsychopharmacology 36 2011 2406 2421
25. Y.J. Choi, S.I. Kim, J.W. Lee, Y.S. Kwon, H.J. Lee, S.S. Kim, and W. Chun Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death Mol. Cell. Neurosci. 49 2012 127 137
26. C. Choudhary, C. Kumar, F. Gnad, M.L. Nielsen, M. Rehman, T.C. Walther, J.V. Olsen, and M. Mann Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325 2009 834 840
27. J.J. Day, and J.D. Sweatt Epigenetic mechanisms in cognition Neuron 70 2011 813 829
28. J.J. Day, and J.D. Sweatt Epigenetic treatments for cognitive impairments Neuropsychopharmacology 37 2012 247 260
29. A.M. Deaton, and A. Bird CpG islands and the regulation of transcription Genes Dev. 25 2011 1010 1022
30. K. Debacker, A. Frizzell, O. Gleeson, L. Kirkham-McCarthy, T. Mertz, and R.S. Lahue Histone deacetylase complexes promote trinucleotide repeat expansions PLoS Biol. 10 2012 e1001257
31. J.P. Dompierre, J.D. Godin, B.C. Charrin, F.P. Cordelieres, S.J. King, S. Humbert, and F. Saudou Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation J. Neurosci. 27 2007 3571 3583 (Pubitemid 46515140)
32. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, S.M. Hersch, M.M. Mouradian, A.B. Young, N. Tanese, and D. Krainc Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243 (Pubitemid 34680312)
33. S. Eustermann, J.C. Yang, M.J. Law, R. Amos, L.M. Chapman, C. Jelinska, D. Garrick, D. Clynes, R.J. Gibbons, D. Rhodes, D.R. Higgs, and D. Neuhaus Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin Nat. Struct. Mol. Biol. 18 2011 777 782
34. R.J. Ferrante, J.K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N.W. Kowall, R.R. Ratan, R. Luthi-Carter, and S.M. Hersch Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J. Neurosci. 23 2003 9418 9427 (Pubitemid 37323042)
35. R.J. Ferrante, H. Ryu, J.K. Kubilus, S. D'Mello, K.L. Sugars, J. Lee, P. Lu, K. Smith, S. Browne, M.F. Beal, B.S. Kristal, I.G. Stavrovskaya, S. Hewett, D.C. Rubinsztein, B. Langley, and R.R. Ratan Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease J. Neurosci. 24 2004 10335 10342 (Pubitemid 39552617)
36. G. Gardian, S.E. Browne, D.K. Choi, P. Klivenyi, J. Gregorio, J.K. Kubilus, H. Ryu, B. Langley, R.R. Ratan, R.J. Ferrante, and M.F. Beal Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease J. Biol. Chem. 280 2005 556 563 (Pubitemid 40165021)
37. C. Giampa, S. Middei, S. Patassini, A. Borreca, F. Marullo, D. Laurenti, G. Bernardi, M. Ammassari-Teule, and F.R. Fusco Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease Eur. J. Neurosci. 29 2009 902 910
38. F. Giorgini, T. Moller, W. Kwan, D. Zwilling, J.L. Wacker, S. Hong, L.C. Tsai, C.S. Cheah, R. Schwarcz, P. Guidetti, and P.J. Muchowski Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment J. Biol. Chem. 283 2008 7390 7400
39. A. Giralt, M. Puigdellivol, O. Carreton, P. Paoletti, J. Valero, A. Parra-Damas, C.A. Saura, J. Alberch, and S. Gines Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity Hum. Mol. Genet. 21 2012 1203 1216
40. P. Giuliano, T. De Cristofaro, A. Affaitati, G.M. Pizzulo, A. Feliciello, C. Criscuolo, G. De Michele, A. Filla, E.V. Avvedimento, and S. Varrone DNA damage induced by polyglutamine-expanded proteins Hum. Mol. Genet. 12 2003 2301 2309 (Pubitemid 37160874)
41. D. Globisch, M. Munzel, M. Muller, S. Michalakis, M. Wagner, S. Koch, T. Bruckl, M. Biel, and T. Carell Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates PLoS One 5 2010 e15367
42. V. Gorbunova, A. Seluanov, D. Mittelman, and J.H. Wilson Genome-wide demethylation destabilizes CTG.CAG trinucleotide repeats in mammalian cells Hum. Mol. Genet. 13 2004 2979 2989 (Pubitemid 39585230)
43. A.V. Goula, A. Stys, J.P. Chan, Y. Trottier, R. Festenstein, and K. Merienne Transcription elongation and tissue-specific somatic CAG instability PLoS Genet. 8 2012 e1003051
44. D.R. Grayson, and A. Guidotti The dynamics of DNA methylation in schizophrenia and related psychiatric disorders Neuropsychopharmacology 38 2013 138 166
45. S. Guibert, and M. Weber Functions of DNA methylation and hydroxymethylation in mammalian development Curr. Top. Dev. Biol. 104 2013 47 83
46. J.U. Guo, D.K. Ma, H. Mo, M.P. Ball, M.H. Jang, M.A. Bonaguidi, J.A. Balazer, H.L. Eaves, B. Xie, E. Ford, K. Zhang, G.L. Ming, Y. Gao, and H. Song Neuronal activity modifies the DNA methylation landscape in the adult brain Nat. Neurosci. 14 2011 1345 1351
47. J.U. Guo, Y. Su, C. Zhong, G.L. Ming, and H. Song Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain Cell 145 2011 423 434
48. S. Henikoff, and A. Shilatifard Histone modification: cause or cog? Trends Genet. 27 2011 389 396
49. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X. Zhou, E. Rosa, K. Sathasivam, S. Ghazi-Noori, A. Mahal, P.A. Lowden, J.S. Steffan, J.L. Marsh, L.M. Thompson, C.M. Lewis, P.A. Marks, and G.P. Bates Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc. Natl. Acad. Sci. U.S.A. 100 2003 2041 2046 (Pubitemid 36254570)
50. P. Hogarth, L. Lovrecic, and D. Krainc Sodium phenylbutyrate in Huntington's disease: a dose-finding study Mov. Disord. 22 2007 1962 1964 (Pubitemid 350134213)
51. M. Hoshino, K. Tagawa, T. Okuda, M. Murata, K. Oyanagi, N. Arai, T. Mizutani, I. Kanazawa, E.E. Wanker, and H. Okazawa Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein J. Neurochem. 87 2003 257 267 (Pubitemid 37210659)
52. Y. Huang, W.A. Pastor, Y. Shen, M. Tahiliani, D.R. Liu, and A. Rao The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing PLoS One 5 2010 e8888
53. S. Igarashi, H. Morita, K.M. Bennett, Y. Tanaka, S. Engelender, M.F. Peters, J.K. Cooper, J.D. Wood, A. Sawa, and C.A. Ross Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation Neuroreport 14 2003 565 568 (Pubitemid 36528991)
54. J. Illuzzi, S. Yerkes, H. Parekh-Olmedo, and E.B. Kmiec DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates J. Neurosci. Res. 87 2009 733 747
55. S. Iwase, B. Xiang, S. Ghosh, T. Ren, P.W. Lewis, J.C. Cochrane, C.D. Allis, D.J. Picketts, D.J. Patel, H. Li, and Y. Shi ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome Nat. Struct. Mol. Biol. 18 2011 769 776
56. M. Jakovcevski, and S. Akbarian Epigenetic mechanisms in neurological disease Nat. Med. 18 2012 1194 1204
57. G.S. Jeon, K.Y. Kim, Y.J. Hwang, M.K. Jung, S. An, M. Ouchi, T. Ouchi, N. Kowall, J. Lee, and H. Ryu Deregulation of BRCA1 leads to impaired spatiotemporal dynamics of gamma-H2AX and DNA damage responses in Huntington's disease Mol. Neurobiol. 45 2012 550 563
58. H. Jeong, F. Then, T.J. Melia Jr., J.R. Mazzulli, L. Cui, J.N. Savas, C. Voisine, P. Paganetti, N. Tanese, A.C. Hart, A. Yamamoto, and D. Krainc Acetylation targets mutant huntingtin to autophagosomes for degradation Cell 137 2009 60 72
59. H. Jia, R.J. Kast, J.S. Steffan, and E.A. Thomas Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems Hum. Mol. Genet. 21 2012 5280 5293
60. H. Jia, J. Pallos, V. Jacques, A. Lau, B. Tang, A. Cooper, A. Syed, J. Purcell, Y. Chen, S. Sharma, G.R. Sangrey, S.B. Darnell, H. Plasterer, G. Sadri-Vakili, J.M. Gottesfeld, L.M. Thompson, J.R. Rusche, J.L. Marsh, and E.A. Thomas Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease Neurobiol. Dis. 46 2012 351 361
61. H. Jiang, F.C. Nucifora Jr., C.A. Ross, and D.B. DeFranco Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein Hum. Mol. Genet. 12 2003 1 12 (Pubitemid 36097710)
62. H. Jiang, M.A. Poirier, Y. Liang, Z. Pei, C.E. Weiskittel, W.W. Smith, D.B. DeFranco, and C.A. Ross Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin Neurobiol. Dis. 23 2006 543 551 (Pubitemid 44234090)
63. S.G. Jin, S. Kadam, and G.P. Pfeifer Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine Nucleic Acids Res. 38 2010 e125
64. J. Jung, and N. Bonini CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease Science 315 2007 1857 1859 (Pubitemid 46580147)
65. C. Kanduri Long noncoding RNA and epigenomics Adv. Exp. Med. Biol. 722 2011 174 195
66. A. Kazantsev, E. Preisinger, A. Dranovsky, D. Goldgaber, and D. Housman Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells Proc. Natl. Acad. Sci. U.S.A. 96 1999 11404 11409 (Pubitemid 29487393)
67. W.Y. Kim, Z. Fayazi, X. Bao, D. Higgins, and P. Kazemi-Esfarjani Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor Mol. Cell. Neurosci. 29 2005 536 544 (Pubitemid 40984695)
68. M.O. Kim, P. Chawla, R.P. Overland, E. Xia, G. Sadri-Vakili, and J.H. Cha Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation J. Neurosci. 28 2008 3947 3957
69. H. Kita, J. Carmichael, J. Swartz, S. Muro, A. Wyttenbach, K. Matsubara, D.C. Rubinsztein, and K. Kato Modulation of polyglutamine-induced cell death by genes identified by expression profiling Hum. Mol. Genet. 11 2002 2279 2287
70. A.M. Klevytska, A.T. Tebbenkamp, A.V. Savonenko, and D.R. Borchelt Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease J. Neuropathol. Exp. Neurol. 69 2010 396 404
71. J. Lee, Y.K. Hong, G.S. Jeon, Y.J. Hwang, K.Y. Kim, K.H. Seong, M.K. Jung, D.J. Picketts, N.W. Kowall, K.S. Cho, and H. Ryu ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington's disease Cell Death Differ. 19 2012 1109 1116
72. J. Lee, Y.J. Hwang, J.Y. Shin, W.C. Lee, J. Wie, K.Y. Kim, M.Y. Lee, D. Hwang, R.R. Ratan, A.N. Pae, N.W. Kowall, I. So, J.I. Kim, and H. Ryu Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease Acta Neuropathol. 125 2013 727 739
73. W. Li, and M. Liu Distribution of 5-hydroxymethylcytosine in different human tissues J. Nucleic Acids 2011 2011 870726
74. S.H. Li, A.L. Cheng, H. Zhou, S. Lam, M. Rao, H. Li, and X.J. Li Interaction of Huntington disease protein with transcriptional activator Sp1 Mol. Cell. Biol. 22 2002 1277 1287 (Pubitemid 34150765)
75. S. Lim, A.S. Chesser, J.C. Grima, P.M. Rappold, D. Blum, S. Przedborski, and K. Tieu d-beta-hydroxybutyrate is protective in mouse models of Huntington's disease PLoS One 6 2011 e24620
76. R. Lister, E.A. Mukamel, J.R. Nery, M. Urich, C.A. Puddifoot, N.D. Johnson, J. Lucero, Y. Huang, A.J. Dwork, M.D. Schultz, M. Yu, J. Tonti-Filippini, H. Heyn, S. Hu, J.C. Wu, A. Rao, M. Esteller, C. He, F.G. Haghighi, T.J. Sejnowski, M.M. Behrens, and J.R. Ecker Global epigenomic reconfiguration during mammalian brain development Science 341 2013 1237905
77. J.P. Lopez-Atalaya, S. Ito, L.M. Valor, E. Benito, and A. Barco Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition Nucleic Acids Res. 41 2013 8072 8084
78. A. Lundby, K. Lage, B.T. Weinert, D.B. Bekker-Jensen, A. Secher, T. Skovgaard, C.D. Kelstrup, A. Dmytriyev, C. Choudhary, C. Lundby, and J.V. Olsen Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns Cell Rep. 2 2012 419 431
79. C. Ma, and S.R. D'Mello Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism J. Biol. Chem. 286 2011 4819 4828
80. E. Martin, S. Betuing, C. Pages, K. Cambon, G. Auregan, N. Deglon, E. Roze, and J. Caboche Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter Hum. Mol. Genet. 20 2011 2422 2434
81. A. McCampbell, J.P. Taylor, A.A. Taye, J. Robitschek, M. Li, J. Walcott, D. Merry, Y. Chai, H. Paulson, G. Sobue, and K.H. Fischbeck CREB-binding protein sequestration by expanded polyglutamine Hum. Mol. Genet. 9 2000 2197 2202
82. A. McCampbell, A.A. Taye, L. Whitty, E. Penney, J.S. Steffan, and K.H. Fischbeck Histone deacetylase inhibitors reduce polyglutamine toxicity Proc. Natl. Acad. Sci. U.S.A. 98 2001 15179 15184 (Pubitemid 34013989)
83. K.N. McFarland, S. Das, T.T. Sun, D. Leyfer, E. Xia, G.R. Sangrey, A. Kuhn, R. Luthi-Carter, T.W. Clark, G. Sadri-Vakili, and J.H. Cha Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease PLoS One 7 2012 e41423
84. M. Mielcarek, C.L. Benn, S.A. Franklin, D.L. Smith, B. Woodman, P.A. Marks, and G.P. Bates SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease PLoS One 6 2011 e27746
85. L. Moumne, K. Campbell, D. Howland, Y. Ouyang, and G.P. Bates Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease PLoS One 7 2012 e31080
86. C. Nestor, A. Ruzov, R. Meehan, and D. Dunican Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA Biotechniques 48 2010 317 319
87. C.W. Ng, F. Yildirim, Y.S. Yap, S. Dalin, B.J. Matthews, P.J. Velez, A. Labadorf, D.E. Housman, and E. Fraenkel Extensive changes in DNA methylation are associated with expression of mutant huntingtin Proc. Natl. Acad. Sci. U.S.A. 110 2013 2354 2359
88. F.C. Nucifora Jr., M. Sasaki, M.F. Peters, H. Huang, J.K. Cooper, M. Yamada, H. Takahashi, S. Tsuji, J. Troncoso, V.L. Dawson, T.M. Dawson, and C.A. Ross Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity Science 291 2001 2423 2428 (Pubitemid 32231807)
89. K. Obrietan, and K.R. Hoyt CRE-mediated transcription is increased in Huntington's disease transgenic mice J. Neurosci. 24 2004 791 796 (Pubitemid 38146589)
90. 2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors J. Neurosci. 26 2006 11174 11186 (Pubitemid 44772205)
91. J. Pallos, L. Bodai, T. Lukacsovich, J.M. Purcell, J.S. Steffan, L.M. Thompson, and J.L. Marsh Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease Hum. Mol. Genet. 17 2008 3767 3775
92. S. Parkel, J. Lopez-Atalaya, and A. Barco Histone H3 lysine methylation in cognition and intellectual disability disorders Learn Mem. 20 2013 570 579
93. M. Piekarski, and A. Jelinska Anthracyclines still prove effective in anticancer therapy Mini Rev. Med. Chem. 13 2013 627 634
94. Z. Qiu, F. Norflus, B. Singh, M.K. Swindell, R. Buzescu, M. Bejarano, R. Chopra, B. Zucker, C.L. Benn, D.P. DiRocco, J.H. Cha, R.J. Ferrante, and S.M. Hersch Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective J. Biol. Chem. 281 2006 16672 16680
95. L. Quinti, V. Chopra, D. Rotili, S. Valente, A. Amore, G. Franci, S. Meade, M. Valenza, L. Altucci, M.M. Maxwell, E. Cattaneo, S. Hersch, A. Mai, and A. Kazantsev Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model PLoS Curr. 2 2010
96. O.J. Rando Combinatorial complexity in chromatin structure and function: revisiting the histone code Curr. Opin. Genet. Dev. 22 2012 148 155
97. E. Roze, S. Betuing, C. Deyts, E. Marcon, K. Brami-Cherrier, C. Pages, S. Humbert, K. Merienne, and J. Caboche Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death FASEB J. 22 2008 1083 1093 (Pubitemid 351519963)
98. H. Ryu, J. Lee, S.W. Hagerty, B.Y. Soh, S.E. McAlpin, K.A. Cormier, K.M. Smith, and R.J. Ferrante ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease Proc. Natl. Acad. Sci. U.S.A. 103 2006 19176 19181 (Pubitemid 350002846)
99. G. Sadri-Vakili, A.S. Menon, L.A. Farrell, C.E. Keller-McGandy, I. Cantuti-Castelvetri, D.G. Standaert, S.J. Augood, G.J. Yohrling, and J.H. Cha Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse Eur. J. Neurosci. 23 2006 3171 3175
100. G. Sadri-Vakili, B. Bouzou, C.L. Benn, M.O. Kim, P. Chawla, R.P. Overland, K.E. Glajch, E. Xia, Z. Qiu, S.M. Hersch, T.W. Clark, G.J. Yohrling, and J.H. Cha Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models Hum. Mol. Genet. 16 2007 1293 1306 (Pubitemid 47055125)
101. T. Seredenina, and R. Luthi-Carter What have we learned from gene expression profiles in Huntington's disease? Neurobiol. Dis. 45 2012 83 98
102. S. Sipione, D. Rigamonti, M. Valenza, C. Zuccato, L. Conti, J. Pritchard, C. Kooperberg, J.M. Olson, and E. Cattaneo Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses Hum. Mol. Genet. 11 2002 1953 1965 (Pubitemid 34919271)
103. J.C. Sng, H. Taniura, and Y. Yoneda Histone modifications in kainate-induced status epilepticus Eur. J. Neurosci. 23 2006 1269 1282
104. C.X. Song, K.E. Szulwach, Y. Fu, Q. Dai, C. Yi, X. Li, Y. Li, C.H. Chen, W. Zhang, X. Jian, J. Wang, L. Zhang, T.J. Looney, B. Zhang, L.A. Godley, L.M. Hicks, B.T. Lahn, P. Jin, and C. He Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine Nat. Biotechnol. 29 2011 68 72
105. E.C. Stack, S.J. Del Signore, R. Luthi-Carter, B.Y. Soh, D.R. Goldstein, S. Matson, S. Goodrich, A.L. Markey, K. Cormier, S.W. Hagerty, K. Smith, H. Ryu, and R.J. Ferrante Modulation of nucleosome dynamics in Huntington's disease Hum. Mol. Genet. 16 2007 1164 1175 (Pubitemid 47062713)
106. J.S. Steffan, A. Kazantsev, O. Spasic-Boskovic, M. Greenwald, Y.Z. Zhu, H. Gohler, E.E. Wanker, G.P. Bates, D.E. Housman, and L.M. Thompson The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription Proc. Natl. Acad. Sci. U.S.A. 97 2000 6763 6768 (Pubitemid 30412788)
107. J.S. Steffan, L. Bodai, J. Pallos, M. Poelman, A. McCampbell, B.L. Apostol, A. Kazantsev, E. Schmidt, Y.Z. Zhu, M. Greenwald, R. Kurokawa, D.E. Housman, G.R. Jackson, J.L. Marsh, and L.M. Thompson Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 2001 739 743 (Pubitemid 33009952)
108. L.B. Strickland-Marmol, A. Khoor, S.K. Livingston, and A. Rojiani Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain Arch. Pathol. Lab. Med. 131 2007 1686 1690 (Pubitemid 350077466)
109. S.J. Tallaksen-Greene, A.B. Crouse, J.M. Hunter, P.J. Detloff, and R.L. Albin Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice Neuroscience 131 2005 843 852 (Pubitemid 40320937)
110. J.P. Taylor, A.A. Taye, C. Campbell, P. Kazemi-Esfarjani, K.H. Fischbeck, and K.T. Min Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein Genes Dev. 17 2003 1463 1468 (Pubitemid 36734703)
111. H. Telenius, B. Kremer, Y.P. Goldberg, J. Theilmann, S.E. Andrew, J. Zeisler, S. Adam, C. Greenberg, E.J. Ives, and L.A. Clarke et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm Nat. Genet. 6 1994 409 414 (Pubitemid 24190028)
112. E.A. Thomas, G. Coppola, P.A. Desplats, B. Tang, E. Soragni, R. Burnett, F. Gao, K.M. Fitzgerald, J.F. Borok, D. Herman, D.H. Geschwind, and J.M. Gottesfeld The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice Proc. Natl. Acad. Sci. U.S.A. 105 2008 15564 15569
113. B. Thomas, S. Matson, V. Chopra, L. Sun, S. Sharma, S. Hersch, H.D. Rosas, C. Scherzer, R. Ferrante, and W. Matson A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease Anal. Biochem. 436 2013 112 120
114. L.M. Thompson, C.T. Aiken, L.S. Kaltenbach, N. Agrawal, K. Illes, A. Khoshnan, M. Martinez-Vincente, M. Arrasate, J.G. O'Rourke, H. Khashwji, T. Lukacsovich, Y.Z. Zhu, A.L. Lau, A. Massey, M.R. Hayden, S.O. Zeitlin, S. Finkbeiner, K.N. Green, F.M. LaFerla, G. Bates, L. Huang, P.H. Patterson, D.C. Lo, A.M. Cuervo, J.L. Marsh, and J.S. Steffan IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome J. Cell Biol. 187 2009 1083 1099
115. N.M. Tsankova, A. Kumar, and E.J. Nestler Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures J. Neurosci. 24 2004 5603 5610 (Pubitemid 38812643)
116. L.M. Valor, and A. Barco Hippocampal gene profiling: towards a systems biology of the hippocampus Hippocampus 22 2012 929 941
117. L.M. Valor, M.M. Pulopulos, M. Jimenez-Minchan, R. Olivares, B. Lutz, and A. Barco Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability J. Neurosci. 31 2011 1652 1663
118. L.M. Valor, D. Guiretti, J.P. Lopez-Atalaya, and A. Barco Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease J. Neurosci. 33 2013 10471 10482
119. L.M. Valor, J. Viosca, J.P. Lopez-Atalaya, and A. Barco Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders Curr. Pharm. Des. 19 2013 5051 5064
120. K.E. Varley, J. Gertz, K.M. Bowling, S.L. Parker, T.E. Reddy, F. Pauli-Behn, M.K. Cross, B.A. Williams, J.A. Stamatoyannopoulos, G.E. Crawford, D.M. Absher, B.J. Wold, and R.M. Myers Dynamic DNA methylation across diverse human cell lines and tissues Genome Res. 23 2013 555 567
121. M. Vashishtha, C.W. Ng, F. Yildirim, T.A. Gipson, I.H. Kratter, L. Bodai, W. Song, A. Lau, A. Labadorf, A. Vogel-Ciernia, J. Troncosco, C.A. Ross, G.P. Bates, D. Krainc, G. Sadri-Vakili, S. Finkbeiner, J.L. Marsh, D.E. Housman, E. Fraenkel, and L.M. Thompson Targeting H3K4 trimethylation in Huntington disease Proc. Natl. Acad. Sci. U.S.A. 110 2013 E3027 3036
122. I. Villar-Menendez, M. Blanch, S. Tyebji, T. Pereira-Veiga, J.L. Albasanz, M. Martin, I. Ferrer, E. Perez-Navarro, and M. Barrachina Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease Neuromolecular Med. 15 2013 295 309
123. Z. Wang, C. Zang, J.A. Rosenfeld, D.E. Schones, A. Barski, S. Cuddapah, K. Cui, T.Y. Roh, W. Peng, M.Q. Zhang, and K. Zhao Combinatorial patterns of histone acetylations and methylations in the human genome Nat. Genet. 40 2008 897 903 (Pubitemid 351913645)
124. F. Wang, Y. Yang, X. Lin, J.Q. Wang, Y.S. Wu, W. Xie, D. Wang, S. Zhu, Y.Q. Liao, Q. Sun, Y.G. Yang, H.R. Luo, C. Guo, C. Han, and T.S. Tang Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease Hum. Mol. Genet. 22 2013 3641 3653
125. W. Xie, C.L. Barr, A. Kim, F. Yue, A.Y. Lee, J. Eubanks, E.L. Dempster, and B. Ren Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome Cell 148 2012 816 831
126. I. Yazawa, N. Hazeki, H. Nakase, I. Kanazawa, and M. Tanaka Histone H3 is aberrantly phosphorylated in glutamine-repeat diseases Biochem. Biophys. Res. Commun. 302 2003 144 149 (Pubitemid 36268932)
127. H.H. Yeh, D. Young, J.G. Gelovani, A. Robinson, Y. Davidson, K. Herholz, and D.M. Mann Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington's disease Brain Res. 1504 2013 16 24
128. Z.X. Yu, S.H. Li, H.P. Nguyen, and X.J. Li Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice Hum. Mol. Genet. 11 2002 905 914
129. D. Zadori, A. Geisz, E. Vamos, L. Vecsei, and P. Klivenyi Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease Pharmacol. Biochem. Behav. 94 2009 148 153
130. M.S. Zajac, T.Y. Pang, N. Wong, B. Weinrich, L.S. Leang, J.M. Craig, R. Saffery, and A.J. Hannan Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice Hippocampus 20 2010 621 636
131. C. Zuccato, M. Valenza, and E. Cattaneo Molecular mechanisms and potential therapeutical targets in Huntington's disease Physiol. Rev. 90 2010 905 981